protege logo

Instance: Fibrinolytic_agents

Types
Own Slots
  Slot Name Value
Alternatives  
CanImprove  
CautionWithMedicationsUsed  
Comment  
Contraindication  
CouldBeRelatedTo Acute_myocardial_infarction, Regional_wall_motion_abnormality, Left_ventricular_thrombus, Any_thromboembolic_event, Low_cardiac_output, Atrial_fibrillation, Coronary_heart_disease, Reduced_heart_contractility
Cui C0016018
Definition Fibrinolysin or agents that convert plasminogen to fibrinolysin (PLASMIN).
DespiteReceivingTreatment  
DoNotUseWithMedicationGroup  
EspeciallyEffectiveAgainst  
Improves Cerebral_infarction, Myocardial_ischemia
Incrementsmgday  
InitiatingDose  
MaintenanceDose  
MaximumRecommendedDailyDose  
MeanDailyDose  
RelevantSignOrSymptom  
SideEffect  
Synonyms Anti-coagulants
TargetDose  
TitrationPeriod  
TreatmentStatus  
Treats  
UMLSSynonyms Antithrombotic_agents
UsedTogetherWithMedication  
UsedWithMedicationGroup  
UseWhenExistsIntoleranceOf  
UseWithTest  

  ^ back to top

Return to Class Hierarchy

Generated: 09/08/2009, 5:06:40 PM, Central European Summer Time

Protégé is a trademark of Stanford University, Copyright (c) 1998-2006 Stanford University.